Want to see WAT full AI Analyst Report?
Earnings Data
Report Date
Aug 04, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
3.01Last Year’s EPS
2.95Same Quarter Last Year
Moderate Buy
Based on 19 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presents a predominantly positive picture: strong combined‑company Q1 results with double‑digit organic growth in legacy businesses, a meaningful EPS beat (+20%), margin outperformance, an above‑plan start for the acquired BD businesses, and raised full‑year guidance. Management also outlined concrete integration actions (180‑day plan), product/regulatory wins, and synergy targets with clear timelines. Offsetting risks include a $20M respiratory headwind, notable China DRG and export constraints that drove declines in parts of the acquired businesses, Q1 GAAP acquisition‑related charges and modest free cash flow impacted by transaction costs, and prudent conservatism baked into the back‑half guide. Overall the positives—beats, raised guidance, tangible synergy progress and product/regulatory milestones—materially outweigh the near‑term operational and geographic headwinds.Company Guidance
Strong Combined Revenue and Organic Growth
Total reported Q1 revenue $1.267B; organic revenue $747M and grew 13% as reported / 11% constant currency versus Q1 2025; orders outpaced sales.
Acquisition Performance Beat
Revenue from Biosciences and Diagnostic Solutions during owned period $520M, beating guidance by $40M; Biosciences: $230M (~7% estimated as‑reported growth); Diagnostic Solutions: $288M (~8% estimated as‑reported growth).
Adjusted EPS and Margin Outperformance
Adjusted EPS grew 20% year‑over‑year to $2.70, beating the high end of guidance by $0.35; adjusted gross margin 54.7% (~200 bps better than expected); adjusted operating margin 23.6% (~200 bps better than expected).
Raised Full‑Year Guidance
Organic constant currency revenue guidance raised to 6.5%–8% for 2026; total reported 2026 revenue now expected ~$6.405B–$6.455B; adjusted EPS guidance raised $0.10 to $14.40–$14.60 (10%–11% growth).
Synergy Progress and Targets on Track
On track to deliver $55M in cost synergies for 2026; targeting $50M in revenue synergies for 2026 with $35M expected contribution from acquired businesses; restructuring savings to start hitting P&L in Q3.
Commercial Execution and Early Revitalization (180‑day Plan)
Launched rapid 180‑day plan to increase forecast rigor, field activity and pricing discipline; increased call volumes and deal desk deployment; initial contract review in U.S. Diagnostics found ~700 out‑of‑compliance contracts (double‑digit million annual opportunity).
Product and Regulatory Milestones
BACTEC FXI blood culture system received CE marking (faster detection, 60-sample loading); FDA cleared BD Onclarity HPV self‑collection kit and assay; launched Microflow LC Chemistry Columns (up to 2x sensitivity) and omniDAWN detector—strengthening differentiation in bioseparations and light scattering.
Instrument Replacement and Service Upside
Identified ~22,000 instruments ripe for replacement (12,000 BACTEC; >50% >5 years old); service plan attachment initiatives expected to generate at least $20M incremental revenue over 5 years; accelerated BACTEC FXI U.S./EU launch by 3–5 months.
WAT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
WAT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 05, 2026 | $301.88 | $342.75 | +13.54% |
Feb 09, 2026 | $381.29 | $328.14 | -13.94% |
Nov 04, 2025 | $345.59 | $367.34 | +6.29% |
Aug 04, 2025 | $290.31 | $285.59 | -1.63% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Waters Corp (WAT) report earnings?
Waters Corp (WAT) is schdueled to report earning on Aug 04, 2026, Before Open (Confirmed).
What is Waters Corp (WAT) earnings time?
Waters Corp (WAT) earnings time is at Aug 04, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is WAT EPS forecast?
WAT EPS forecast for the fiscal quarter 2026 (Q2) is 3.01.